SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
yutou
Lv2
140 积分
2022-09-06 加入
最近求助
最近应助
互助留言
FOLFIRI Plus Durvalumab With or Without Tremelimumab in Second-Line Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
6天前
已完结
Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial
10天前
已完结
NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial
10天前
已完结
Treatment of Recurrent Epithelial Ovarian Cancer
2个月前
已关闭
Bevacizumab plus irinotecan with or without gamma knife radiosurgery after failure of concurrent chemo-radiotherapy for high-grade glioma
2个月前
已完结
Combination Chemotherapy of Cisplatin, Ifosfamide, and Irinotecan with rhG-CSF Support in Patients with Brain Metastases from Non-Small Cell Lung Cancer
3个月前
已关闭
Complete response of brain metastases to irinotecan-based chemotherapy
3个月前
已关闭
Neoadjuvant chemotherapy with FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy for borderline resectable and resectable pancreatic cancer (PREOPANC-2): a multicenter randomized controlled trial
4个月前
已完结
A phase 2 study of liposomal irinotecan with 5-fluorouracil and leucovorin in squamous cell carcinoma of head and neck or esophagus after prior platinum-based chemotherapy or chemoradiotherapy
4个月前
已关闭
Faculty Opinions recommendation of Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial
4个月前
已关闭
没有进行任何应助
找到了【积分已退回】
2个月前
不需要了【积分已退回】
4个月前
不需要了【积分已退回】
4个月前
已找到【积分已退回】
4个月前
感谢,点赞,速度真快,帮大忙了
1年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论